The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

Following the Healthcare Dollar

In this advanced program, learn about how money is introduced to the healthcare system and divided amongst stakeholders involved in drug distribution

$650

The Medicare & Medicaid Programs

Learn about the Medicare and Medicaid Programs, focusing on benefit design, patient cost-sharing, and program design changes that impact product access.

$500

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

$650

The Medicare & Medicaid Programs

Learn about the Medicare and Medicaid Programs, focusing on benefit design, patient cost-sharing, and program design changes that impact product access.

$500

Following the Healthcare Dollar

In this advanced program, learn about how money is introduced to the healthcare system and divided amongst stakeholders involved in drug distribution

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

The Medicare & Medicaid Programs

Learn about the Medicare and Medicaid Programs, focusing on benefit design, patient cost-sharing, and program design changes that impact product access.

The Current and Future State of Healthcare

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway to the healthcare system

Manufacturers Restricting 340B Sales to Contract Pharmacies

  • Abbvie
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Sanofi
  • UCB
  • United Therapeutics
  • and more…